Esophageal disease: Updated information on inflammation

Annals of the New York Academy of Sciences

Volumn 1232, Issue 1, 2011, Pages 369-375

  Orlando, Roy C ^a   Paterson, William G ^b   Harnett, Karen M ^c   Ma, Jie ^a   Behar, Jose ^c   Biancani, Piero ^c   Guarino, Michele Pier Luca ^d   Altomare, Annamaria ^d   Cicala, Michele ^d   Cao, Weibiao ^c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b QUEEN S UNIVERSITY   (Canada)

^c RHODE ISLAND HOSPITAL   (United States)

^d UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

Adenocarcinoma; Adherens junction; Chemosensitive nociceptors; Claudins; Cytokines; Dilated intercellular spaces; E cadherin; Esophagitis; Gastro esophageal reflux; Inflammatory mediators; Nonerosive reflux disease; NOX5 S; Paracellular permeability; Platelet activating factor; Squamous cells; Substance P; TGR5; Tight junction; TRPV 1 receptor

Indexed keywords

BILE ACID; CHEMOKINE; CYTOKINE; PEPSIN A; THROMBOCYTE ACTIVATING FACTOR; VANILLOID RECEPTOR;

ARTICLE; BARRETT ESOPHAGUS; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGITIS; ESOPHAGUS DISEASE; ESOPHAGUS MUCOSA; HUMAN; MAST CELL; NONHUMAN; REFLUX ESOPHAGITIS; TUMOR GROWTH;

EID: 80053217540     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2011.06064.x     Document Type: Article

References (22)

1. Orlando, R.C. 2004. Pathophysiology of gastroesophageal reflux disease: esophageal epithelial resistance. In: The Esophagus, D.O. Castell & J.E. Richter, Eds.: 421-433. Lippincott Williams & Wilkins. Philadelphia .
2. Tobey, N.A., Z. Djukic, L.E. Brighton, et al Lateral cell membranes and shunt resistance in rabbit esophageal epithelium. Dig. Dis. Sci. 55: 1856-1865.
3. Asaoka, D., H. Miwa, S. Hirai, et al 2005. Altered localization and expression of tight-junction proteins in a rat model with chronic acid reflux esophagitis. J. Gastroenterol. 40: 781-790.
4. Jovov, B.J., Z. Djukic, N.J. Shaheen, & R.C. Orlando 2009. E-cadherin cleavage in GERD. Gastroenterology 136: M1834.
5. Barlow, W.J. & R.C. Orlando 2005. The pathogenesis of heartburn in nonerosive reflux disease: a unifying hypothesis. Gastroenterology 128: 771-778.
6. Orlando, R.C. 2003. Pathogenesis of gastroesophageal reflux disease. Am. J. Med. Sci. 326: 274-278.
7. Ma, J., K.M. Harnett, J. Behar, et al 2010. Signaling in TRPV1-induced platelet activating factor (PAF) in human esophageal epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 298: G233-G240.
8. Barclay, R.L., P.K. Dinda, G.P. Morris & W.G. Paterson 1995. Morphological evidence of mast cell degranulation in an animal model of acid-induced esophageal mucosal injury. Dig. Dis. Sci. 40: 1651-1658.
9. Paterson, W.G., C.A. Kieffer, M.J. Feldman, et al 2007. Role of platelet- activating factor in acid-induced esophageal mucosal injury. Dig. Dis. Sci. 52: 1861-1866.
10. Feldman, M.J., G.P. Morris, P.K. Dinda, & W.G. Paterson 1996. Mast cells mediate acid-induced augmentation of opossum esophageal blood flow through a Histamine- and Nitric Oxide-dependent mechanism. Gastroenterology 110: 121-128.
11. Cheng, L., S. de la Monte, J. Ma, et al 2009. HCl-activated neural and epithelial vanilloid receptors (TRPV1) in cat esophageal mucosa. Am. J. Physiol. Gastrointest. Liver Physiol. 297: G135-G143.
12. Ma, J., K.M. Harnett, J. Behar, et al. 2010. Signaling in TRPV1-induced platelet activating factor (PAF) in human esophageal epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 298: G233-G240.
13. Ma, J., A. Altomare, S. De la Monte, et al. 2010. HCl-induced inflammatory mediators in esophageal mucosa increase migration and production of H2O2 by peripheral blood leukocytes. Am. J. Physiol. Gastrointest. Liver Physiol. 299: G791-G798.
14. Modlin, I.M., R.H. Hunt, P. Malfertheiner, et al 2009. Diagnosis and management of non- erosive reflux disease - the Vevey NERD Consensus Group. Digestion 80: 74-88.
15. Emerenziani, S., D. Sifrim, F.I. Habib, et al 2008. Presence of gas in the refluxate enhances reflux perception in non-erosive patients with physiological acid exposure of the oesophagus. Gut 57: 443-447.
16. Caviglia, R., M. Ribolsi, M. Gentile, et al 2007. Dilated intercellular spaces and acid reflux at the distal and proximal oesophagus in patients with non-erosive gastro-oesophageal reflux disease. Aliment Pharmacol. Ther. 25: 629-636.
17. Guarino, M.P., L. Cheng, J. Ma, et al 2010. Increased TRPV1 gene expression in esophageal mucosa of patients with non-erosive and erosive reflux disease. Neurogastroenterol Motil 22: 746-751.
18. Hong, J., M. Resnick, J. Behar, et al Acid-induced p16 hypermethylation contributes to development of esophageal adenocarcinoma via activation of NADPH oxidase NOX5-S. Am. J. Physiol. Gastrointest. Liver Physiol. 299: G697-G6706.
19. Fu, X., D.G. Beer, J. Behar, et al ., 2006. cAMP-response element- binding protein mediates acid-induced NADPH oxidase NOX5-S expression in Barrett esophageal adenocarcinoma cells. J. Biol. Chem. 281: 20368-20382.
20. Bernstein, H., C. Bernstein, C.M. Payne, et al 2005. Bile acids as carcinogens in human gastrointestinal cancers. Mutat. Res. 589: 47-65.
21. Hong, J., J. Behar, J. Wands, et al Role of a novel bile acid receptor TGR5 in the development of oesophageal adenocarcinoma. Gut 59: 170-180.
22. Hong, J., J. Behar, J. Wands, et al Bile acid reflux contributes to development of esophageal adenocarcinoma via activation of phosphatidylinositol-specific phospholipase Cgamma2 and NADPH oxidase NOX5-S. Cancer Res. 70: 1247-1255.